Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · Real-Time Price · USD

2.940

-0.460 (-13.53%)

At close: Aug 14, 2026, 4:00 PM EDT

2.990

+0.050 (1.70%)

After-hours: Aug 14, 2026, 7:55 PM EDT

Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.8	21.62	8.71	16.9	22.64	45.04
Cash & Short-Term Investments	9.8	21.62	8.71	16.9	22.64	45.04
Cash Growth	4.11%	148.09%	-48.45%	-25.32%	-49.75%	12.67%
Accounts Receivable	-	-	-	-	2.5	3.66
Receivables	-	-	-	-	2.5	3.66
Prepaid Expenses	1	0.61	0.93	1.47	1.57	1.82
Restricted Cash	-	-	-	-	-	1.26
Other Current Assets	-	0.85	1.02	0.69	0.74	0.78
Total Current Assets	10.8	23.08	10.66	19.07	27.45	52.57
Property, Plant & Equipment	3.72	4.11	4.93	5.78	6.77	3.96
Other Long-Term Assets	0	-	-	-	-	0.07
Total Assets	14.52	27.19	15.59	24.84	34.22	56.6
Accounts Payable	1.16	0.88	1.24	3.98	3.5	3.46
Accrued Expenses	3.11	4.31	4.2	2.1	2.11	2.08
Current Portion of Long-Term Debt	-	-	-	-	2	11.67
Current Portion of Leases	0.92	0.87	0.77	-	0.42	-
Current Unearned Revenue	-	-	-	-	-	15.47
Other Current Liabilities	-	-	-	1.14	0.68	2.09
Total Current Liabilities	5.19	6.05	6.21	7.22	8.71	34.76
Long-Term Debt	-	-	-	-	1.46	3.71
Long-Term Leases	3.29	3.76	4.63	5.4	6.08	1.34
Long-Term Unearned Revenue	-	-	-	-	-	15.58
Total Liabilities	8.48	9.81	10.84	12.62	16.24	55.39
Common Stock	0.11	0.11	0.08	0.06	0.05	0.05
Additional Paid-In Capital	294.19	292.38	252.25	235.61	223.96	215.23
Retained Earnings	-288.26	-275.12	-247.58	-223.45	-206.04	-214.06
Shareholders' Equity	6.04	17.38	4.76	12.22	17.97	1.22
Total Liabilities & Equity	14.52	27.19	15.59	24.84	34.22	56.6
Total Debt	4.21	4.63	5.4	5.4	9.96	16.72
Net Cash (Debt)	5.59	16.99	3.32	11.51	12.68	28.33
Net Cash Growth	26.97%	412.21%	-71.17%	-9.24%	-55.24%	125.46%
Net Cash Per Share	6.27	53.85	-	-	-	-
Filing Date Shares Outstanding	1.8	1.18	-	-	-	-
Total Common Shares Outstanding	1.42	1	-	-	-	-
Working Capital	5.61	17.03	4.45	11.84	18.74	17.81
Book Value Per Share	4.26	17.42	-	-	-	-
Tangible Book Value	6.04	17.38	4.76	12.22	17.97	1.22
Tangible Book Value Per Share	4.26	17.42	-	-	-	-
Machinery	-	12.22	12.26	12.26	12.26	12.43
Leasehold Improvements	-	2.23	2.23	2.23	2.23	2.23

SEC Filings: 10-K · 10-Q